AI-Driven Biomarkers: Transforming Cancer Detection Through Multimodal Intelligence will be a cornerstone of next-generation precision oncology.

Byadmin

AI-Driven Biomarkers: Transforming Cancer Detection Through Multimodal Intelligence Introduction The integration of artificial intelligence (AI) into healthcare has revolutionized biomedical research, diagnostics, and patient care. One of the most promising applications lies in the development of AI-driven biomarkers—computationally identified features from diverse biological data types that can be used to detect, diagnose, or predict disease….

RNA Polymerase II Levels in Histone Genes: A Predictive Biomarker for Tumor Aggressiveness and Recurrence

Byadmin

RNA Polymerase II Levels in Histone Genes: A Predictive Biomarker for Tumor Aggressiveness and Recurrence Introduction Histone genes play a fundamental role in DNA packaging and chromatin structure, and their expression is tightly regulated during the cell cycle, particularly in S-phase. RNA Polymerase II (RNAPII), the enzyme responsible for transcribing protein-coding genes, including replication-dependent histone…

OnCofirm Rapid Cancer Tests electronic cassette reader
|

OncoFirm™ Electronic Reader

Byadmin

OncoFirm™ Electronic Reader cassette reader* (detailed information coming soon)… Cutting-Edge Digital Cancer Diagnostics Solutions Lateral Flow Electronic Reader (LFER) technology is an advanced diagnostic tool used to enhance and quantify results from lateral flow assays (LFAs), which are common in rapid tests like pregnancy or COVID-19 tests. While traditional LFAs are visual (relying on colored…

Thomsen-Friedenreich (TF) antigen
| | |

Thomsen-Friedenreich (TF) antigen

Byadmin

​The Thomsen–Friedenreich (TF) antigen, also known as CD176, is a disaccharide structure comprising galactose and N-acetylgalactosamine (Galβ1-3GalNAcα1-Ser/Thr). It serves as the core 1 structure in O-linked glycosylation of proteins. In healthy tissues, the TF antigen is typically masked by additional carbohydrate chains or sialylation, rendering it inaccessible to the immune system. However, in many cancer…